Sterling Capital Management’s Medtronic MDT Stock Holding History

Sterling Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$216K	Buy	2,495 +21	+0.8%	+$2.01K	﹤0.01%	1144
2025 Q4	$238K	Sell	2,474 -36,226	-94%	-$3.52M	﹤0.01%	1261
2025 Q3	$3.69M	Buy	38,700 +34,389	+798%	+$3.16M	0.05%	236
2025 Q2	$376K	Sell	4,311 -22,568	-84%	-$1.91M	0.01%	1058
2025 Q1	$2.42M	Buy	26,879 +497	+2%	+$44.5K	0.04%	309
2024 Q4	$2.11M	Sell	26,382 -1,857	-7%	-$161K	0.03%	391
2024 Q3	$2.54M	Buy	+28,239	New	+$2.38M	0.03%	327
2019 Q3	$114M	Sell	1,046,185 -8,721	-0.8%	-$910K	1.08%	14
2019 Q2	$103M	Buy	1,054,906 +20,200	+2%	+$1.84M	0.99%	18
2019 Q1	$94.2M	Buy	1,034,706 +65,632	+7%	+$5.87M	0.93%	19
2018 Q4	$88.1M	Buy	969,074 +2,075	+0.2%	+$194K	0.96%	18
2018 Q3	$95.1M	Sell	966,999 -5,263	-0.5%	-$487K	0.86%	28
2018 Q2	$83.2M	Sell	972,262 -3,172	-0.3%	-$265K	0.78%	42
2018 Q1	$78.2M	Buy	975,434 +86,901	+10%	+$7.17M	0.74%	45
2017 Q4	$71.7M	Buy	888,533 +796,118	+861%	+$63.8M	0.65%	54
2017 Q3	$7.19M	Buy	92,415 +5,887	+7%	+$489K	0.07%	212
2017 Q2	$7.68M	Sell	86,528 -7,934	-8%	-$669K	0.07%	204
2017 Q1	$7.61M	Sell	94,462 -2,809	-3%	-$219K	0.07%	207
2016 Q4	$6.93M	Buy	97,271 +28,080	+41%	+$2.21M	0.06%	212
2016 Q3	$5.98M	Sell	69,191 -3,724	-5%	-$325K	0.06%	219
2016 Q2	$6.33M	Sell	72,915 -2,478	-3%	-$200K	0.06%	221
2016 Q1	$5.65M	Buy	75,393 +1,964	+3%	+$148K	0.05%	234
2015 Q4	$5.65M	Buy	73,429 +2,852	+4%	+$215K	0.05%	237
2015 Q3	$4.72M	Sell	70,577 -6,114	-8%	-$450K	0.04%	249
2015 Q2	$5.68M	Sell	76,691 -11,800	-13%	-$902K	0.05%	182
2015 Q1	$6.9M	Buy	+88,491	New	+$6.71M	0.06%	154
2014 Q4	–	Sell	-62,710	Closed	-$3.88M	–	939
2014 Q3	$3.88M	Buy	62,710 +19,098	+44%	+$1.21M	0.05%	216
2014 Q2	$2.78M	Buy	43,612 +19,894	+84%	+$1.21M	0.02%	256
2014 Q1	$1.46M	Buy	23,718 +19,828	+510%	+$1.15M	0.01%	461
2013 Q4	$223K	Buy	+3,890	New	+$221K	﹤0.01%	762

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sterling Capital Management's MDT Position: Q1 2026 in Review

Sterling Capital Management increased its Medtronic (MDT) stake by 0.85% in Q1 2026, buying an estimated $2.01K and bringing the position to 2,495 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #1144.

Sterling Capital Management first reported a position in MDT in Q4 2013 and has held it in 30 quarters since. The position peaked at $114M in Q3 2019. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Sterling Capital Management held 2,495 shares of Medtronic worth $216K as of Q1 2026.
Sterling Capital Management bought 21 Medtronic shares in Q1 2026, an estimated $2.01K.
Medtronic made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #1144 holding.
Sterling Capital Management first reported a position in Medtronic in Q4 2013 and has held it in 30 quarters since.
Sterling Capital Management's Medtronic position peaked at $114M in Q3 2019.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.